Nitric oxide modulates tumor cell death induced by photodynamic therapy through a cGMP-dependent mechanism

Photochemistry and Photobiology

Volumn 76, Issue 4, 2002, Pages 423-430

  Gomes, Edgar R ^a   Almeida, Ramiro D ^a   Carvalho, Arsélio P ^a   Duarte, Carlos B ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

1 [(2 AMINOETHYL) N (2 AMMONIOETHYL)AMINO]DIAZEN 1 IUM 1,2 DIOLATE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC GMP; ARGININE; CASPASE; CASPASE 9; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; GUANYLATE CYCLASE INHIBITOR; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; HYDROXYLAMINE; KT 5823; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; PHTHALOCYANINE ALUMINUM; PROTEIN BCL 2; SINGLET OXYGEN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PROTEIN EXPRESSION; TUMOR GROWTH; CELL CULTURE; DRUG EFFECT; PHOTOCHEMOTHERAPY; PHYSIOLOGY;

APOPTOSIS; CYCLIC GMP; HUMANS; NITRIC OXIDE; NITRIC OXIDE DONORS; PHOTOCHEMOTHERAPY; TUMOR CELLS, CULTURED;

EID: 0036782294     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2002)076<0423:NOMTCD>2.0.CO;2     Document Type: Article

References (64)

1. Moore, J. V., C. M. L. West and C. Whitehurst (1997) The biology of photodynamic therapy. Phys. Med. Biol. 42, 913-935.
2. Moan, J. and K. Berg (1991) The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem. Photobiol. 53, 549-553.
3. Peng, Q. and J. Moan (1995) Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma. Br. J. Cancer 72, 565-574.
4. Ahmad, N. and H. Mukhtar (2000) Mechanism of photodynamic therapy-induced cell death. Methods Enzymol. 319, 342-358.
5. Peng, Q., J. Moan, G. Farrants, H. E. Danielsen and C. Rimington (1990) Localization of potent photosensitizers in human tumor LOX by means of laser scanning microscopy. Cancer Lett. 53, 129-139.
6. Peng, Q., J. Moan, J. M. Nesland and C. Rimington (1990) Aluminum phthalocyanines with asymmetrical lower sulfonation and with symmetrical higher sulfonation: a comparison of localizing and photosensitizing mechanism in human tumor LOX xenografts. Int. J. Cancer 46, 719-726.
7. Tozer, G. M., V. E. Prise and D. J. Chaplin (1997) Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. Cancer Res. 57, 948-955.
8. Jadeski, L. C., K. O. Hum, C. Chakraborty and P. K. Lala (2000) Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int. J. Cancer 86, 30-39.
9. Korbelik, M., C. S. Parkins, H. Shibuya, I. Cecic, M. R. Stratford and D. J. Chaplin (2000) Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy. Br. J. Cancer 82, 1835-1843.
10. Henderson, B., T. M. Sitnik-Busch and L. A. Vaughan (1999) Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent. Photochem. Photobiol. 70, 64-71.
11. Liu, L. and J. S. Stamler (1999) NO: an inhibitor of cell death. Cell Death Differ. 6, 937-942.
12. Gomes, E. R., T. Cruz, C. F. Lopes, A. P. Carvalho and C. B. Duarte (1999) Photosensitization of lymphoblastoid cells with phthalocyanines at different saturating incubation times. Cell Biol. Toxicol. 15, 249-260.
13. Chan, W. S., N. Brasseur, C. Lamadeleine, R. Ouellet and J. E. Vanlier (1997) Efficacy and mechanism of aluminium phthalocyanine and its sulphonated derivatives mediated photodynamic therapy on murine tumours. Eur. J. Cancer. 33, 1855-1859.
14. Luo, Y. and D. Kessel (1997) Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine. Photochem. Photobiol. 66, 479-483.
15. Kessel, D., Y. Luo, Y. Q. Deng and C. K. Chang (1997) The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem. Photobiol. 65, 422-426.
16. Zou, H., Y. C. Li, H. S. Liu and X. D. Wang (1999) An APAF-1-cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274, 11549-11556.
17. Thornberry, N. A. and Y. Lazebnik (1998) Caspases: enemies within. Science 281, 1312-1316.
18. Earnshaw, W. C., L. M. Martins and S. H. Kaufmann (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68, 383-424.
19. Melino, G., M. V. Catani, M. Corazzari, P. Guerrieri and F. Bernassola (2000) Nitric oxide can inhibit apoptosis or switch it into necrosis. Cell. Mol. Life Sci. 57, 612-622.
20. Rossig, L., B. Fichtlscherer, K. Breitschopf, J. Haendeler, A. M. Zeiher, A. Mulsch and S. Dimmeler (1999) Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J. Biol. Chem. 274, 6823-6826.
21. Dimmeler, S., J. Haendeler, M. Nehls and A. M. Zeiher (1997) Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 185, 601-607.
22. Genaro, A. M., S. Hortelano, A. Alvarez, C. Martinez and L. Bosca (1995) Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J. Clin. Investig. 95, 1884-1890.
23. Kim, Y. M., H. T. Chung, S. S. Kim, J. A. Han, Y. M. Yoo, K. M. Kim, G. H. Lee, H. Y. Yun, A. Green, J. Li, R. L. Simmons and T. R. Billiar (1999) Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J. Neurosci. 19, 6740-6747.
24. Kim, Y. M., R. V. Talanian and T. R. Billiar (1997) Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J. Biol. Chem. 272, 31138-31148.
25. Komalavilas, P., P. K. Shah, H. Jo and T. M. Lincoln (1999) Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J. Biol. Chem. 274, 34301-34309.
26. Gudi, T., G. K. Hong, A. B. Vaandrager, S. M. Lohmann and R. B. Pilz (1999) Nitric oxide and cGMP regulate gene expression in neuronal and glial cells by activating type II cGMP-dependent protein kinase. FASEB J. 13, 2143-2152.
27. Marshall, H. E. and J. S. Stamler (2001) Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 40, 1688-1693.
28. Lohmann, S. M., A. B. Vaandrager, A. Smolenski, U. Walter and H. R. De Jonge (1997) Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem. Sci. 22, 307-312.
29. Koesling, D. (1998) Modulators of soluble guanylyl cyclase. Arch. Pharmacol. 358, 123-126.
30. Lucas, K. A., G. M. Pitari, S. Kazerounian, I. Ruiz-Stewart, J. Park, S. Schulz, K. P. Chepenik and S. A. Waldman (2000) Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. 52, 375-414.
31. Pfeifer, A., P. Ruth, W. Dostmann, M. Sausbier, P. Klatt and F. Hofmann (1999) Structure and function of cGMP-dependent protein kinases. Rev. Physiol. Biochem. Pharmacol. 135, 105-149.
32. Smolenski, A., A. M. Burkhardt, M. Eigenthaler, E. Butt, S. Gambaryan, S. M. Lohmann and U. Walter (1998) Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects. Arch. Pharmacol. 358, 134-139.
33. Keilbach, A., P. Ruth and F. Hofmann (1992) Detection of cGMP dependent protein kinase isozymes by specific antibodies. Eur. J. Biochem. 208, 467-473.
34. Foresti, R. and R. Motterlini (1999) The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic. Res. 31, 459-475.
35. Suschek, C. V., V. Krischel, D. Bruch-Gerharz, D. Berendji, J. Krutmann, K. D. Kroncke and V. Kolb-Bachofen (1999) Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl-2 up-regulation. J. Biol. Chem. 274, 6130-6137.
36. Kim, Y. M., M. E. Devera, S. C. Watkins and T. R. Billiar (1997) Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem. 272, 1402-1411.
37. Oleinick, N. L. and H. H. Evans (1998) The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat. Res. 150, S146-S156.
38. Kessel, D. and Y. Luo (1998) Mitochondrial photodamage and PDT-induced apoptosis. J. Photochem. Photobiol. B: Biol. 42, 89-95.
39. Kessel, D. and Y. Luo (2001) Intracellular sites of photodamage as a factor in apoptotic cell death. J. Porphyrins Phthalocyanines 5, 181-184.
40. Peng, Q., G. W. Farrants, K. Madslien, J. C. Bommer, J. Moan, H. E. Danielsen and J. M. Nesland (1991) Subcellular localization, redistribution and photobleaching of sulfonated aluminum phthalocyanines in a human melanoma cell line. Int. J. Cancer 49, 290-295.
41. Peng, Q., J. Moan and J. M. Nesland (1996) Correlation of subcellular and intratumoral photosensitizer localization with ultraestructural features after photodynamic therapy. Ultrastruct. Pathol. 20, 109-129.
42. Ketabchi, A., A. MacRobert, P. M. Speight and J. H. Bennett (1998) Induction of apoptotic cell death by photodynamic therapy in human keratinocytes. Arch. Oral Biol. 43, 143-149.
43. Li, J. R., C. A. Bombeck, S. F. Yang, Y. M. Kim and T. R. Billiar (1999) Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes. J. Biol. Chem. 274, 17325-17333.
44. Kim, Y. M., T. H. Kim, D. W. Seol, R. V. Talanian and T. R. Billiar (1998) Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. J. Biol. Chem. 273, 31437-31441.
45. Mannick, J. B., K. Asano, K. Izumi, E. Kieff and J. S. Stamler (1994) Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79, 1137-1146.
46. Hebestreit, H., B. Dibbert, I. Balatti, D. Braun, A. Schapowal, K. Blaser and H. U. Simon (1998) Disruption of Fas receptor signaling by nitric oxide in eosinophils. J. Exp. Med. 187, 415-425.
47. Fernandez-Tome, P., I. Lizasoain, J. C. Leza, P. Lorenzo and M. A. Moro (1999) Neuroprotective effects of DETA-NONOate, a nitric oxide donor, on hydrogen peroxide-induced neurotoxicity in cortical neurones. Neuropharmacology 38, 1307-1315.
48. Wink, D. A., I. Hanbauer, M. C. Krishna, W. G. DeGraff, J. Gamson and J. B. Mitchell (1993) Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. USA 90, 9813-9817.
49. Joshi, M. S., J. L. Ponthier and J. R. Lancaster (1999) Cellular antioxidant and pro-oxidant actions of nitric oxide. Free Radic. Biol. Med. 27, 1357-1366.
50. Kanner, J., S. Harel and R. Granit (1991) Nitric oxide as an antioxidant. Arch. Biochem. Biophys. 289, 130-136.
51. Wink, D. A., Y. Vodovotz, M. B. Grisham, W. DeGraff. J. C. Cook, R. Pacelli, M. Krishna and J. B. Mitchell (1999) Antioxidant effects of nitric oxide. Methods Enzymol. 301, 413-424.
52. Rubbo, H., R. Radi, M. Trujillo, R. Telleri, B. Kalyanaraman, S. Barnes, M. Kirk and B. A. Freeman (1994) Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. 269, 26066-26075.
53. Fischer, T. A., A. Palmetshofer, S. Gambaryan, E. Butt, C. Jassoy, U. Walter, S. Sopper and S. M. Lohmann (2001) Activation of cGMP-dependent protein kinase Iβ inhibits interleukin 2 release and proliferation of T cell receptor-stimulated human peripheral T cells. J. Biol. Chem. 276, 5967-5974.
54. Wang, X. and P. J. Robinson (1997) Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J. Neurochem. 68, 443-456.
55. von Knethen, A., D. Callsen and B. Brune (1999) NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol. Biol. Cell 10, 361-372.
56. Pilz, R. B., M. Suhasini, S. Idriss, J. L. Meinkoth and G. R. Boss (1995) Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J. 9, 552-558.
57. Xu, W., L. Liu, G. C. M. Smith and I. G. Charles (2000) Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents. Nat. Cell Biol. 2, 339-345.
58. Marshall, H. E., K. Merchant and J. S. Stamler (2000) Nitrosation and oxidation in the regulation of gene expression. FASEB J. 14, 1889-1900.
59. Lander, H. M., P. Sehajpal, D. M. Levine and A. Novogrodsky (1993) Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150, 1509-1516.
60. Lander, H. M., J. S. Ogiste, S. F. Pearce, R. Levi and A. Novogrodsky (1995) Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J. Biol. Chem. 270, 7017-7020.
61. Taylor, B. S., Y. M. Kim, Q. Wang, R. A. Shapiro, T. R. Billiar and D. A. Geller (1997) Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch. Surg. 132, 1177-1183.
62. Sekkai, D., F. Aillet, N. Israel and M. Lepoivre (1998) Inhibition of NF-kappaB and HIV-1 long terminal repeat transcriptional activation by inducible nitric oxide synthase 2 activity. J. Biol. Chem. 273, 3895-3900.
63. Peng, H. B., P. Libby and J. K. Liao (1995) Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270, 14214-14219.
64. Shin, W. S., Y. H. Hong, H. B. Peng, R. De Caterina, P. Libby and J. K. Liao (1996) Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma. The role of constitutive NF-kappa B activity. J. Biol. Chem. 271, 11317-11324.